Your web browser is out of date.

For your security and improved experience online, please update your browser.

This site is intended for healthcare professionals only
×
Share this article
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email
Share on print
Print

Early blood pressure control reduces atherosclerotic event risk

Cardiovascular – December 2019 digest

Early hypertensive control in adults with diabetes reduces the chance of atherosclerotic cardiovascular disease

Raghavan S, Ho YL, Kini V et al (2019) Association between early hypertension control and cardiovascular disease incidence in veterans with diabetes. Diabetes Care 42: 1995–2003

  • Good blood pressure control reduces the risk of cardiovascular disease; however, the target blood pressure and optimal threshold at which to initiate antihypertensive treatment remain unclear in adults with diabetes.
  • In this retrospective study, researchers followed almost 44,000 individuals with diabetes who were started on antihypertensive therapy over a 5-year period to determine the impact systolic blood pressure (SBP) had on atherosclerotic cardiovascular disease events (fatal and non-fatal stroke and myocardial infarction).
  • Patients were split into groups according to their SBP when starting antihypertensive treatment and 2 years later.
  • Patients with higher pre-treatment SBP (³140 mmHg) had a greater risk of atherosclerotic cardiovascular disease events during the 9.3-year follow-up period than those with lower pre-treatment SBP (130–139 mmHg); this risk remained higher in patients who achieved on-treatment SBP of 120–129 mmHg when compared to those with a pre-treatment SBP of 130–139 mmHg.
  • There was a higher risk of adverse outcomes in individuals with higher on-treatment SBP at 2 years when compared to those with lower on-treatment SBP at this point in time.
  • It was concluded that better outcomes resulted from starting antihypertensive treatment when SBP was 130–139 mmHg and when achieving on-treatment SBP of <130 mmHg.

Click here to access the article in full

Share this article
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on whatsapp
For the latest news and articles

Sign up to all DiabetesontheNet journals

© Copyright Omniamed Communications. All Rights Reserved​
108 Cannon Street, London, EC4N 6EU. Registered in the United Kingdom​
Omniamed logo white
For the latest news and articles

Sign up to all DiabetesontheNet journals

 

By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.

DiabetesontheNet Logo

This website is for UK healthcare professionals only. To continue, please confirm that you are a UK healthcare professional below.